Apotex Mulls Toronto IPO That Could Raise Up to C$1 Billion in First Half
Canadian generic drug maker Apotex Inc. is preparing for a potential initial public offering in Toronto during the first half of the year that could raise as much as C$1 billion (about $730 million). Bank advisers have been engaged, but final decisions on timing and deal size have not been made and plans remain subject to change.